Intravascular ultrasound: a guide for management of complications during intervention?
Within a few years, intravascular ultrasound (IVUS) has emerged from a research tool into an intrinsic part of modern invasive cardiology, mainly because histology can be obtained 'in-vivo'. For the first time in invasive cardiology it is possible to base decisions not only on lumenograms but also on vessel wall assessment. IVUS can be used as both a diagnostic tool and for intervention purposes. Its diagnostic strength lies in its ability to monitor compensatory coronary artery enlargement as a response to arteriosclerosis, to reveal occult left main stem disease, and angiographically 'silent' arteriosclerosis. As regards intervention, IVUS aids in optimal device selection, i.e. whether to use rotablators in calcified lesions or atherectomy devices in large plaques. The effects of PTCA on vessel wall morphology can be studied in great detail and the effect on luminal gain assessed almost on-line. Several groups have shown that the residual plaque area, even after angiographically successful PTCA, is about 60%. A significant reduction in this percentage may influence long-term outcome after PTCA. Luminal areas that are minimal after PTCA seem to indicate restenosis, while morphological appearance on its own seems to be less predictive. One answer to the shortcomings of standard PTCA are coronary artery stents. Intravascular monitoring of stent expansion led to the deployment of high-pressure stents with a significant increase in post-procedural luminal diameters, and finally the ability to withhold anticoagulation in patients with optimal stent deployment. Furthermore, integrated devices, such as balloons on IVUS catheters, steerable catheters, integrated flow measurements, pressure transducers, and, hopefully, tissue characterization, will further enhance the usefulness of IVUS.